Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

 Mobic (Meloxicam) Oral Suspension
Company:  Boehringer Ingelheim Pharmaceutical, Inc.
Application No.:  021530
Approval Date: 06/01/2004

 

Date created: March 202006

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-